(Q53207519)
Statements
The cost-effectiveness of lanthanum carbonate in the treatment of hyperphosphatemia in patients with end-stage renal disease. (English)
Ron Akehurst
Sarah Davis
Hana Sakai
Victoria Abbott
1 January 2007
10
1
32-41